Abdulla Tarmahomed

Abdulla Tarmahomed

Auto-generated profile, based on publicly available information

Abdulla Tarmahomed

Department of Paediatric Cardiology, Alder Hey Children Hospital, Liverpool, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2021 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
AAAmr Ashry
Amr Ashry
AHAmer Harky
Amer Harky
ATAbdulla Tarmahomed
Abdulla Tarmahomed
CUChristopher Ugwu
Christopher Ugwu
HMHeba M. Mohammed
Heba M. Mohammed
RDRamana Dhannapuneni
Ramana Dhannapuneni
Objectives: There are several studies reporting the outcomes of hypoplastic aortic arch and aortic coarctation repair with combination of techniques. However, only few studies reported of aortic arch and coarctation repair using a homograft patch through sternotomy and circulatory arrest with antegrade cerebral perfusion. We report our experience and outcomes of this cohort of neonates and infants.Methods: We performed retrospective data collection for all neonates and infants who underwent aortic arch reconstruction between 2015 and 2020 at our institute. Data are presented as median and inter-quartile range (IQR).Results: The cohort included 76 patients: 49 were males (64.5%). Median age at operation was 16 days (IQR 9–43.25 days). Median weight was 3.5 kg (IQR 3.10–4 kg). There was no 30 days mortality. Three patients died in hospital after 30 days (3.95%), neurological adverse events occurred in only one patient (1.32%) and recurrent laryngeal nerve injury was noted in four patients (5.26%). Only three patients required the support of extracorporeal membrane oxygenation (ECMO) with a median ECMO run of 4 days. Median follow-up was 35 months (IQR 18.9–46.4 months); 5 years survival was 93.42% (n = 71). The rate of re-intervention on the aortic arch was 9.21% (n = 7).Conclusion: Our experience shows excellent outcomes in repairing aortic arch hypoplasia with homograft patch under moderate to deep hypothermia with low in-hospital and 5 years mortality rates.

23 October 2022 in World Journal for Pediatric and Congenital Heart Surgery
Verified
Journal Article
Closed access
AAAmr Ashry
Amr Ashry
ATAbdulla Tarmahomed
Abdulla Tarmahomed
MJMelonie Johns
Melonie Johns
ASAvishek Samaddar
Avishek Samaddar
RKRamesh Kutty
Ramesh Kutty
RGRafael Guerrero
Rafael Guerrero
A 9-year-old girl presented with a recent history of shortness of breath, fatigue, visual disturbances, and gastrointestinal symptoms. Echocardiography demonstrated three large intracardiac masses in the right and left atria protruding into the mitral and tricuspid valve orifices causing bilateral inflow obstruction. She underwent urgent surgical excision of the masses. Histology revealed rare intracardiac Burkitt's Lymphoma.

1 July 2026 in Open Heart
Verified
Journal Article
Open access
PDF file
ATAbdulla Tarmahomed
Abdulla Tarmahomed
TBThomas W Binnersley
Thomas W Binnersley
CDCharlotte Davidson
Charlotte Davidson
ACAdrian Crucean
Adrian Crucean
EPEsther Poole
Esther Poole
RDRami Dhillon
Rami Dhillon
Objective: To compare long-term outcomes following balloon aortic valvuloplasty (BAV) and surgical aortic valvotomy (SAV), including surgical valvuloplasty for isolated severe congenital aortic valve stenosis (AVS). Data for mechanical aortic valve replacement and pulmonary autograft replacement are also presented to provide a complete institutional cohort overview. Methods: Retrospective single-centre cohort study including patients aged 65 mm Hg and/or mean gradient >40 mm Hg. Primary outcome was all-cause mortality. Secondary outcomes were time to reintervention and time to aortic valve replacement (AVR)—mechanical or autograft. Kaplan-Meier and Cox regression analyses were performed. Results: A total of 231 patients met inclusion criteria (96 BAV, 112 SAV, 23 other). Median age at intervention was lower in the SAV group (0.2 years vs 3.74 years, p<0.001). Overall survival was 99.4% at 10 years and 92.3% at 25 years, with no statistically significant difference between BAV and SAV (p=0.083), though a trend may exist. Reintervention occurred in 49% of patients overall, with similar rates between BAV and SAV (p=0.950). Freedom from mechanical or autograft AVR remained high (75% at 10 years; 67% at 25 years), with no significant difference between strategies (p=0.190). Neonatal intervention was associated with significantly lower freedom from reintervention (p<0.0001). Conclusions: Long-term survival following intervention for severe congenital AVS is excellent and comparable between BAV and SAV. Reintervention is common, particularly in neonates, but progression to AVR less so. These findings support continued multidisciplinary, anatomy-guided decision-making and highlight the importance of life-course management strategies. Development of a national AVS registry is indicated.